ELSIE

Twelve years later, ELSIE is a thriving consortium of 22 diverse companies, spanning biotech, pharma, and medical devices. ELSIE continues to be the preeminent organization recognized for its expert knowledge of E&Ls in the biopharmaceutical and medical device industry... The Extractables and Leachables Safety Information Exchange (ELSIE) was established in 2007, when Doug Ball (then at Pfizer) and Jon Cammack (then at Baxter) brought together leading scientists to advance the concept of sharing pre-competitive safety information on extractables and leachables, among industry. The vision was that such a collaborative effort would reduce duplicative safety studies across companies, streamline development projects, and allow industry and other stakeholders to share experiences and information to help advance the practice and science of extractables, leachables and materials evaluation. A driving ethos for ELSIE's formation, as articulated by founding Board member Lewis Kinter (then at..

Primary location: Washington United States